Article Details
Retrieved on: 2018-03-18 23:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Supernus Pharmaceuticals logo <b>BlackRock Inc</b>. increased its position in Supernus Pharmaceuticals (NASDAQ:SUPN) by 1.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,902,230 shares of the specialty pharmaceutical ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here